Haemonetics Corporation (HAE) Social Stream



Haemonetics Corporation (HAE): $76.42

-0.53 (-0.69%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

HAEMONETICS CORP (HAE) Price Targets From Analysts

Use the tables below to see what analysts covering HAEMONETICS CORP think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 8 $108 $68 $81.571 $77.55 5.19%
2021-11-10 8 $108 $68 $78.428 $77.55 1.13%
2022-01-06 8 $108 $59 $76 $77.55 -2%
2022-01-07 8 $108 $59 $74.857 $77.55 -3.47%
2022-02-08 7 $108 $59 $74.285 $77.55 -4.21%
2022-04-11 8 $108 $59 $75.428 $77.55 -2.74%
2022-05-10 7 $80 $59 $67.4 $77.55 -13.09%
2022-05-11 7 $80 $59 $67.8 $77.55 -12.57%
2022-07-14 5 $80 $59 $72.4 $77.55 -6.64%
2022-09-15 6 $90 $59 $79.8 $77.55 2.9%

The Trend in the Analyst Price Target


Over the past 15 months, HAE's average price target has gone down $0.49.

HAE reports an average of 27.49% for its upside potential over the past 44 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-12-15 8 108 59 76.000 50.63 50.11%
2022-01-07 7 108 59 74.857 52.63 42.23%
2022-04-11 8 80 59 70.000 58.97 18.7%
2022-04-11 8 108 59 75.428 58.97 27.91%
2022-09-15 6 90 59 79.800 77.64 2.78%

HAE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.17 2 1 3 0 0 6

The Trend in the Broker Recommendations


Over the past 28 months, HAE's average broker recommendation rating worsened by 1.03.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, HAEMONETICS CORP's upside potential (average analyst target price relative to current price) is higher than 86.55% of them.
  • In the context of stocks in the mid market cap category, HAEMONETICS CORP's average analyst price target is greater than 1127.84% of them.
  • To contextualize these metrics, consider that out of Medical Equipment stocks, HAEMONETICS CORP's variance in analysts' estimates is lower than -810.58% of them.
  • In terms of how HAEMONETICS CORP fares relative to Healthcare stocks, note that its number of analysts covering the stock is greater than 829.84% of that group.

In terms of price targets and recommendations offered by analysts, the stocks in the Medical Equipment industry with the ratings most similar to HAEMONETICS CORP are GMED, GKOS, and ATRC.

Is HAE a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.531 seconds.